• Director Continuing Education Projects- Dep’t family and Community Medicine University 
Of Toronto, Faculty of Medicine, University of Toronto, August 2003- present
  • Family Practice in Toronto, Albany Clinic, Active Staff: Toronto East General Hospital
  • Colin Woolf Award for Long-term Contribution to Continuing Education from the U of T 
Faculty of Medicine, 2010 co-winner
  • Member – Professional Development Committee of The Department of Family and 
Community Medicine of University of Toronto, 2003 – Present



Since 1998 – present at Albany Clinic: Principal Investigator for Ten phase III & IV studies:

For example:

  • BOEHRINGER INGLEHEIM Canada LTD. trial #244.2484 A 6 month double blind (within 
formulation ) randomized multiple dose trial to compare the safety and efficacy of 20 mcg and 40 mcg of ipratropium bromide as delivered by the respimat device to 18 mcg atrovent inhalation aerosol (x2 puffs) and respective placebos in adults with chronic obstructive pulmonary disease.
  • A Double Blind Placebo-controlled study of Lansoprazole, Clarithromycin and amoxicillin in Eradication of H.Pylori in Non-Ulcer Dyspepsia Patients. Abbott C96-006

Since 1998 – present at the Albany Clinic: Co-Investigator for 37 phase III Research studies:

For example:

  • A 12 week Randonized Double-Blind,Placebo-Controlled,Parallel-Group,DoseRanging Phase 
II study to Assess the Clinical Efficacy of Alosetron(GF68755) in Male Subjects with 
irritable Bowel Syndrome. Glaxo Wellcome
  • Pennsiad – Study Double Blind active controlled, 5 way parallel trial to evaluate safety and 
efficacy of Pennsaid along with oral diclofenac in the treatment of osteoarthritis knee pain.



  • MD PASSPORT Nutrition e-Newsletter | March 2012 Issue 41 “Nutrition Myths: Late Night Snacking.” [Contribute Regular monthly column since 2007]
  • Axler, J. (2006). eGFR Reporting: A Primary Care Perspective NephroSPECTIVE 1(2). September.
  • Axler, J. (2005). Practical Patient Experiences in Infertility. Obstetrics And Gynecology: Aug/Sept

Axler, J. (2001). The Role of Angiotension II Receptor Blockers in Heart Failure Perspectives In Cardiology: March